BOTULINUM TOXIN THERAPY IN THE TREATMENT OF SPASTIC TYPE OF CEREBRAL PALSY IN CHILDREN: SIDE EFFECTS AND THEIR PREVENTION

Authors

  • Ermatov Farhod Akhmedovich Central Asian Medical University Assistant of the Department of Pediatrics and Pediatric Surgery Independent Doctoral Researcher

Keywords:

cerebral palsy in children, spasticity, botulinum toxin, botulinum therapy, side effects, prevention.

Abstract

Spastic type of cerebral palsy (CP) in children results from congenital or early childhood injury to the central nervous system. Spasticity is the leading clinical symptom in this condition. Currently, botulinum toxin (BTX) is widely used in the treatment of spastic CP. This article analyzes the clinical efficacy of botulinum toxin therapy, possible side effects, and methods for their prevention.

Downloads

Download data is not yet available.

References

Heinen F, et al. "The updated European Consensus 2021 on Botulinum toxin for children with cerebral palsy."

Fehlings D, Novak I, et al. "Botulinum toxin in the management of children with cerebral palsy: an evidence-based review."

Delgado MR, et al. "Practice parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy."

Graham HK, et al. "A systematic review of botulinum toxin for spasticity in children with cerebral palsy."

Boyd RN, et al. "Cerebral palsy: clinical and research perspectives."

Tashkent – 2025

Downloads

Published

2025-06-19

How to Cite

Ermatov Farhod Akhmedovich. (2025). BOTULINUM TOXIN THERAPY IN THE TREATMENT OF SPASTIC TYPE OF CEREBRAL PALSY IN CHILDREN: SIDE EFFECTS AND THEIR PREVENTION. Journal of Applied Science and Social Science, 15(06), 570–572. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/1310